The DOI matches its OpenAlex record; 7 of the 7 references it cites were found in a registry or an index.
The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension
Abstract
The contribution of obesity to cardiovascular risk has not been adequately appreciated because of a failure to recognize the involvement of upper-body predominance of body weight with hypertension, diabetes, and hypertriglyceridemia even in the absence of significant overall obesity. This article examines the evidence that upper-body obesity, as usually induced by caloric excess in the presence of androgens, mediates these problems by way of hyperinsulinemia. Because of these interrelationships, there is a need to identify and prevent upper-body obesity or, failing that, to provide therapies that will control the associated problems without aggravating hyperinsulinemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Insulin Resistance in Essential Hypertension
Ferrannini, E., Buzzigoli, G., Bonadonna, R., Giorico, M. A., Oleggini, M., Graziadei, L., Pedrinelli, R., Brandi, L., & Bevilacqua, S. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708063170605 · Cited by 2,344
Hyperinsulinemia. A link between hypertension obesity and glucose intolerance.
Modan, M., Halkin, H., Almog, S., Lusky, A., Eshkol, A., Shefi, M., Shitrit, A., & Fuchs, Z. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111776 · Cited by 1,465
Effect of Insulin and Glucose Infusions on Sympathetic Nervous System Activity in Normal Man
Rowe, J. W., Young, J. B., Minaker, K. L., Stevens, A. L., Pallotta, J., & Landsberg, L. (1981) · Diabetes · doi:10.2337/diab.30.3.219 · Cited by 1,143
Incidence and precursors of hypertension in young adults: The Framingham offspring study
Garrison, R. J., Kannel, W. B., Stokes, J., & Castelli, W. P. (1987) · Preventive Medicine · doi:10.1016/0091-7435(87)90087-9 · Cited by 789
Epinephrine-induced insulin resistance in man
Deibert, D. C., & Defronzo, R. A. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109718 · Cited by 557
LANDSBERG, L. (1986) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068066 · Cited by 373
Splanchnic insulin metabolism in obesity. Influence of body fat distribution.
Peiris, A. N., Mueller, R. A., Smith, G. A., Struve, M. F., & Kissebah, A. H. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112758 · Cited by 346
Cited by
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961
Alberti, K. G. M. M., Zimmet, P., & Shaw, J. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01858.x · Cited by 6,597
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Berenson, G. S., Srinivasan, S. R., Bao, W., Newman, W. P., Tracy, R. E., & Wattigney, W. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806043382302 · Cited by 4,032
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
Kadowaki, T. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29126 · Cited by 2,824
Cornier, M.-A., Dabelea, D., Hernandez, T. L., Lindstrom, R. C., Steig, A. J., Stob, N. R., Van Pelt, R. E., Wang, H., & Eckel, R. H. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0024 · Cited by 2,162
Turner, R. C., Millns, H., Neil, H. A. W., Stratton, I. M., Manley, S. E., Matthews, D. R., & Holman, R. R. (1998) · BMJ · doi:10.1136/bmj.316.7134.823 · Cited by 2,014
A comprehensive review on metabolic syndrome
Kaur, J. (2014) · Cardiology Research and Practice · doi:10.1155/2014/943162 · Cited by 1,889
RetractedHyperinsulinemia as an independent risk factor for ischemic heart disease
Després, J.-P., Lamarche, B., Mauriège, P., Cantin, B., Dagenais, G. R., Moorjani, S., & Lupien, P.-J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604113341504 · Cited by 1,699
Kinoshita, M., Yokote, K., Arai, H., Iida, M., Ishigaki, Y., Ishibashi, S., Umemoto, S., Egusa, G., Ohmura, H., Okamura, T., et al. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2017 · Cited by 813
Berenson, G. S., Wattigney, W. A., Tracy, R. E., Newman, W. P., Srinivasan, S. R., Webber, L. S., Dalferes, E. R., & Strong, J. P. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90726-f · Cited by 591
Effects of exercise and diet on chronic disease
Roberts, C. K., & Barnard, R. J. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00852.2004 · Cited by 556
A clinical perspective of obesity, metabolic syndrome and cardiovascular disease
Han, T. S., & Lean, M. E. (2016) · JRSM Cardiovascular Disease · doi:10.1177/2048004016633371 · Cited by 500
Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease
Matsuzawa, Y. (2006) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0380 · Cited by 434
The sympathetic nervous system and the metabolic syndrome
Mancia, G., Bousquet, P., Elghozi, J. L., Esler, M., Grassi, G., Julius, S., Reid, J., & Van Zwieten, P. A. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e328048d004 · Cited by 385
Boyanov, M. A., Boneva, Z., & Christov, V. G. (2003) · The Aging Male · doi:10.1080/tam.6.1.1.7 · Cited by 381
Prevalence and Characteristics of the Metabolic Syndrome in Primary Aldosteronism
Fallo, F., Veglio, F., Bertello, C., Sonino, N., Della Mea, P., Ermani, M., Rabbia, F., Federspil, G., & Mulatero, P. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1733 · Cited by 372
Roberts, C. K., Barnard, R. J., Sindhu, R. K., Jurczak, M., Ehdaie, A., & Vaziri, N. D. (2006) · Metabolism · doi:10.1016/j.metabol.2006.02.022 · Cited by 322
Saito, Y., Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., et al. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.06.003 · Cited by 316
Epidemiologic trends in overweight and obesity
Ogden, C. L., Carroll, M. D., & Flegal, K. M. (2003) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(03)00074-4 · Cited by 282
Obesity and hypertension: two epidemics or one?
Davy, K. P., & Hall, J. E. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00707.2003 · Cited by 280
Prevalence of the Metabolic Syndrome Among Omani Adults
Al-Lawati, J. A., Mohammed, A. J., Al-Hinai, H. Q., & Jousilahti, P. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1781 · Cited by 267
Sexual differences in the control of energy homeostasis
Shi, H., Seeley, R. J., & Clegg, D. J. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.03.004 · Cited by 242
The Metabolic Syndrome and Inflammation
Sutherland, J. P., McKinley, B., & Eckel, R. H. (2004) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2004.2.82 · Cited by 243
Prevalence of the metabolic syndrome in drug‐treated hypertensive patients and control subjects
Rantala, A. O., Kauma, H., Lilja, M., Savolainen, M. J., Reunanen, A., & Kesäniemi, Y. A. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00429.x · Cited by 211
Hiuge-Shimizu, A., Kishida, K., Funahashi, T., Ishizaka, Y., Oka, R., Okada, M., Suzuki, S., Takaya, N., Nakagawa, T., Fukui, T., et al. (2012) · Annals of Medicine · doi:10.3109/07853890.2010.526138 · Cited by 205
Secondary causes of hyperlipidemia.
Stone, N. J. (1994) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30179-1 · Cited by 199
Pambianco, G., Costacou, T., & Orchard, T. J. (2007) · Diabetes Care · doi:10.2337/dc06-2053 · Cited by 198
Mechanisms of endothelial dysfunction in obesity.
Avogaro, A., & de Kreutzenberg, S. V. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2005.04.020 · Cited by 188
Oxidative DNA damage and obesity in type 2 diabetes mellitus
Al-Aubaidy, H. A., & Jelinek, H. F. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0053 · Cited by 183
Hak, A. E., Pols, H. A. P., Stehouwer, C. D. A., Meijer, J., Kiliaan, A. J., Hofman, A., Breteler, M. M. B., & Witteman, J. C. M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7873 · Cited by 184
Anti-hyperglycemic and anti-hyperlipidemic effects of guava leaf extract
Deguchi, Y., & Miyazaki, K. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-9 · Cited by 170
Novel opportunities for next-generation probiotics targeting metabolic syndrome
Cani, P. D., & Van Hul, M. (2015) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2014.10.006 · Cited by 167
TAKEUCHI, H., SAITOH, S., TAKAGI, S., OHNISHI, H., OHHATA, J., ISOBE, T., & SHIMAMOTO, K. (2005) · Hypertension Research · doi:10.1291/hypres.28.203 · Cited by 164
Kang, E. S., Yun, Y. S., Park, S. W., Kim, H. J., Ahn, C. W., Song, Y. D., Cha, B. S., Lim, S. K., Kim, K. R., & Lee, H. C. (2005) · Metabolism · doi:10.1016/j.metabol.2004.08.014 · Cited by 161
(2007) · doi:10.1139/h06-102 · Cited by 160
Chinali, M., Devereux, R. B., Howard, B. V., Roman, M. J., Bella, J. N., Liu, J. E., Resnick, H. E., Lee, E. T., Best, L. G., & de Simone, G. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.09.009 · Cited by 157
Association of metabolic syndrome and chronic kidney disease
Scurt, F. G., Ganz, M. J., Herzog, C., Bose, K., Mertens, P. R., & Chatzikyrkou, C. (2024) · Obesity Reviews · doi:10.1111/obr.13649 · Cited by 155
Metabolic syndrome: Does it differ between women and men?
Rochlani, Y., Pothineni, N. V., & Mehta, J. L. (2015) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-015-6593-6 · Cited by 152
Scaglione, S., Di Chiara, T., Daidone, M., & Tuttolomondo, A. (2025) · Nutrients · doi:10.3390/nu17020358 · Cited by 92
Jones, D. (1999) · American Journal of Hypertension · doi:10.1016/s0895-7061(99)00123-5 · Cited by 89
Obesity exacerbates chemically induced neurodegeneration
Sriram, K., Benkovic, S. A., Miller, D. B., & O’Callaghan, J. P. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00306-8 · Cited by 78
Insulin resistance and the metabolic syndrome—or the pitfalls of epidemiology
Yudkin, J. S. (2007) · Diabetologia · doi:10.1007/s00125-007-0711-3 · Cited by 75
Hirose, H., Takayama, T., Hozawa, S., Hibi, T., & Saito, I. (2011) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2011.09.005 · Cited by 72
Sinha, S. K., Thakur, R., Jha, M. J., Goel, A., Kumar, V., Kumar, A., Mishra, V., Varma, C. M., Krishna, V., Singh, A. K., et al. (2016) · Journal of Clinical Medicine Research · doi:10.14740/jocmr2468w · Cited by 71
Distribution of renal medullary hyaluronan in lean and obese rabbits
Dwyer, T. M., Banks, S. A., Alonso-Galicia, M., Cockrell, K., Carroll, J. F., Bigler, S. A., & Hall, J. E. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00218.x · Cited by 68
HEDIGER, M. L., SCHOLL, T. O., & SCHALL, J. I. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48214.x · Cited by 67
Weight control among obese adolescents: a pilot study
Williams, C. L., Strobino, B. A., & Brotanek, J. (2007) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637480701198083 · Cited by 62
The Role of the Autonomic Nervous System in Hypertension.
Amerena, J., & Julius, S. (1995) · Hypertension Research · doi:10.1291/hypres.18.99 · Cited by 63
The transient hypercholesterolemia of major weight loss
Phinney, S., Tang, A., Waggoner, C., Tezanos-Pinto, R., & Davis, P. (1991) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/53.6.1404 · Cited by 45
Okamura, T., Kokubo, Y., Watanabe, M., Higashiyama, A., Ono, Y., Nishimura, K., Okayama, A., & Miyamoto, Y. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.03.010 · Cited by 38
Okamura, T., Sugiyama, D., Tanaka, T., & Dohi, S. (2014) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2013.09.011 · Cited by 33
Lowering LDL cholesterol in adults: a prospective, community-based practice initiative
Coodley, G. O., Jorgensen, M., Kirschenbaum, J., Sparks, C., Zeigler, L., & Albertson, B. D. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.02.031 · Cited by 23
Low serum ZAG levels correlate with determinants of the metabolic syndrome in Chinese subjects
Wang, L., Liu, M., Ning, D., Zhu, H., Shan, G., Wang, D., Ping, B., Yu, Y., Yang, H., Yan, K., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00154 · Cited by 21
“(2) To explore the associations between serum ZAG levels and the MetS components.”
BackgroundWatanabe, S., Katsube, T., Hattori, H., Sato, H., Ishijima, T., Nakai, Y., Abe, K., & Sonomoto, K. (2013) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2013.01.009 · Cited by 18
Metadata
- Authors
- Kaplan, N. M.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 1989-07-01
- Volume
- 149
- Issue
- 7
- Pages
- 1514
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2069371982
- Cited by
- 1,516
- References
- 7
- FWCI
- 11.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.